AQR Capital Management’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $634K | Buy |
130,084
+16,985
| +15% | +$82.7K | ﹤0.01% | 2478 |
|
|
2025
Q1 | $418K | Buy |
+113,099
| New | +$418K | ﹤0.01% | 2528 |
|
|
2024
Q4 | – | Sell |
-37,936
| Closed | -$264K | – | 2942 |
|
|
2024
Q3 | $264K | Buy |
+37,936
| New | +$264K | ﹤0.01% | 2451 |
|
|
2022
Q3 | – | Sell |
-13,988
| Closed | -$129K | – | 2307 |
|
|
2022
Q2 | $129K | Sell |
13,988
-10,541
| -43% | -$97.2K | ﹤0.01% | 2054 |
|
|
2022
Q1 | $442K | Buy |
24,529
+20,750
| +549% | +$374K | ﹤0.01% | 1863 |
|
|
2021
Q4 | $99K | Sell |
3,779
-4,161
| -52% | -$109K | ﹤0.01% | 2151 |
|
|
2021
Q3 | $285K | Sell |
7,940
-6,768
| -46% | -$243K | ﹤0.01% | 2047 |
|
|
2021
Q2 | $807K | Buy |
14,708
+3,985
| +37% | +$219K | ﹤0.01% | 1677 |
|
|
2021
Q1 | $889K | Buy |
+10,723
| New | +$889K | ﹤0.01% | 1604 |
|
|
2019
Q3 | – | Sell |
-2,953
| Closed | -$255K | – | 2151 |
|
|
2019
Q2 | $255K | Buy |
+2,953
| New | +$255K | ﹤0.01% | 1917 |
|